Iaso Therapeutics, Inc. funding
Iaso Therapeutics, Inc., a biotechnology company based in East Lansing, MI, filed a Form D with the SEC on January 14, 2026 and reported $570K raised of a $1.8M offering.
Amount raised$570K
Offering size$1.8M
Filed with the SECJanuary 14, 2026
First saleJanuary 9, 2026
IndustryBiotechnology
SecuritiesOptions or warrants
LocationEast Lansing, MI
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment$25K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jan 14